SOPHiA GENETICS (SOPH) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
SOPHiA GENETICS has announced strategic leadership changes with Ross Muken promoted to President and George Cardoza appointed as the new Chief Financial Officer. Muken, who has been with the company since 2021, will now oversee global operations and strategic planning. Cardoza brings over 30 years of financial expertise in precision medicine, poised to strengthen SOPHiA GENETICS’ growth trajectory.
For further insights into SOPH stock, check out TipRanks’ Stock Analysis page.